Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
about
Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention SolutesIndoxyl Sulfate-Review of Toxicity and Therapeutic StrategiesRegulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubulesLocalization and functional characterization of the rat Oatp4c1 transporter in an in vitro cell system and rat tissuesAn update on uremic toxins.Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunctionIndoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells.Indoxyl sulphate and kidney disease: Causes, consequences and interventions.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacyMetabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosisLocalization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones.Uremic Solutes in Chronic Kidney Disease and Their Role in ProgressionMetabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.Pharmacokinetic drug-drug interactions with methotrexate in oncology.The impact of drug transporters on adverse drug reaction.Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease.New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.The intestine and the kidneys: a bad marriage can be hazardous.Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds.Direct inhibition and down-regulation by uremic plasma components of hepatic uptake transporter for SN-38, an active metabolite of irinotecan, in humans.The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function.Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells.Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry.Bioengineered kidney tubules efficiently excrete uremic toxins.SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation.The influence of renal transplantation on retained microbial-human co-metabolites.Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Hemodialysis Decreases the Concentration of Accumulated Plant Phenols in the Plasma of Patients on Maintenance Dialysis: Influence of Residual Renal Function.Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells.Effect of mechanistic target of rapamycin inhibitors on postrenal transplantation malignancy: A nationwide cohort study
P2860
Q26784008-F6B21F41-ECEC-4D3A-9ABA-8C286492EEE9Q28075033-AFA1C500-5643-4CC0-A6E4-F5C5637E425EQ28390004-E7F1F583-7B11-4BCC-AB4A-000836F6A1E4Q28480934-4125ED50-BFC4-4B0A-8153-98E8F4C0EB2FQ34641464-E9E10228-F802-48D5-88A3-106F610DAAEAQ34775724-91D749C8-4788-4325-8F76-44F2D79C8716Q34846428-B1B67798-C0EC-4FF0-85C3-3656D5AEB56CQ34926535-E8246D90-A35F-4D29-8F74-9DB3E11BCB85Q35688446-33A1B24D-AACF-495D-A6F5-41FC7652EC6AQ35736317-D17180A3-F3C3-4EB7-BACB-0FB47D99D686Q35891553-757F2DD4-1347-4EC0-B4E1-44018216E878Q36100197-918A4B79-873C-489F-ADBF-0C20D8B4965AQ36150190-185DC8DF-B8CD-4BE8-9675-4D11635E7AE9Q36235662-A5AE760A-60F1-4092-A474-4EDC0EED8946Q37069948-877CD024-3F9B-420E-8644-4A4FA7C154FDQ37246931-23B08ED2-506C-4D17-9640-4BBD5933980CQ37960131-F8DBDD76-8923-435F-B5E4-3854356D3941Q38075820-6063DA3C-9A5E-45D3-9540-0C7FE278C25BQ38094065-DAED01F1-5F67-41F7-8456-304135579058Q38274050-3408C87F-0324-4F2A-B537-AA3CD30D8A5BQ38393212-E2BC3C9E-124D-487D-ADF2-3107BFA1A1E0Q38747526-D5947A6D-E188-47DD-A978-67F0608375DEQ39114407-17359242-FEE0-4C5B-93BE-285A78203B11Q39342998-A1430CCE-3868-4A91-9581-5778462E4443Q39393524-80022ED9-AB63-4FE6-9C4D-FB2C4C297908Q41420103-82129B58-A4BD-4A48-8E7C-69F074680FF2Q42025247-68BB2DE2-010F-45D9-A9CE-D985C06A769BQ43648786-843D4AAB-1D73-4A58-BCF7-E1AD41A15DDAQ46582267-CAD70A58-FBD8-4C1E-A2EE-B0C6A635A1A2Q46675919-2FC9EE88-C777-4EB5-8DD8-A4DBAA5B4B54Q47216784-758BAEAE-3A9E-4C35-944C-5EC9811104D8Q47674972-A9BC7D51-3D21-49C0-97B3-F6AF5CC180D7Q48150663-2D7D2398-3918-4551-902B-AA0168D8BF42Q50108575-CE17B0F9-34F3-43C3-9826-C05D8D019B5EQ53659964-9BC0B9B0-9121-4600-AD26-40C8BA96A4EEQ58772577-AA3D0288-C0EB-4B9B-91E9-C8C03D021F36
P2860
Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Uremic toxins inhibit transpor ...... cally relevant concentrations.
@ast
Uremic toxins inhibit transpor ...... cally relevant concentrations.
@en
type
label
Uremic toxins inhibit transpor ...... cally relevant concentrations.
@ast
Uremic toxins inhibit transpor ...... cally relevant concentrations.
@en
prefLabel
Uremic toxins inhibit transpor ...... cally relevant concentrations.
@ast
Uremic toxins inhibit transpor ...... cally relevant concentrations.
@en
P2093
P2860
P50
P1433
P1476
Uremic toxins inhibit transpor ...... ically relevant concentrations
@en
P2093
Anita C A Dankers
Jack F M Wetzels
Joost G Hoenderop
Lambertus P van den Heuvel
Lauke H J Ringens
P2860
P304
P356
10.1371/JOURNAL.PONE.0018438
P407
P577
2011-04-04T00:00:00Z